Recently, the “Intracranial Aneurysm-Assisted Embolization Stent,” a device of high interest in the neurointerventional field, has been officially approved for market by China’s National Medical Products Administration
The MissilEX® Intracranial Thrombectomy Stent System, supported by CCRC Medtech’s full-cycle clinical trial services, has recently received marketing authorization from China’s National Medical Products Administration (NMPA).
On July 25, the inaugural member conference and innovation salon of the Baoshan District Biopharmaceutical Industry Association was successfully held in Shanghai. As a key
Recently, the “Intracranial Aneurysm-Assisted Embolization Stent,” a device of high interest in the neurointerventional field, has been officially approved for market by China’s National Medical Products Administration
The MissilEX® Intracranial Thrombectomy Stent System, supported by CCRC Medtech’s full-cycle clinical trial services, has recently received marketing authorization from China’s National Medical Products Administration (NMPA).
On July 25, the inaugural member conference and innovation salon of the Baoshan District Biopharmaceutical Industry Association was successfully held in Shanghai. As a key
March 2025 – A landmark study validating the Analytics for Life (A4L) non-invasive coronary artery disease (CAD) detection system for mainland Chinese populations was published in Discover Medicine by Professor Qian
